Highlands Oncology Group - Fayetteville is a clinical research site located in Fayetteville, Arkansas, United States 72703.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Highlands Oncology Group - Fayetteville has participated in 20 clinical trials with 15 currently active.
Therapeutic areas: Prostate Carcinoma, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma.
Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), SWOG Cancer Research Network.
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology Group - Fayetteville has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology Group - Fayetteville has 20 clinical trials on record, with 15 currently active. Their work covers Prostate Carcinoma, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma.
Highlands Oncology Group - Fayetteville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.